Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

How Molecular Testing is Used in the Treatment of Brain Tumors


Published on

Patrick Wen, MD, director of Dana-Farber's Center for Neuro-Oncology, discusses how molecular testing can help guide treatment decisions for patients with glioblastoma, meningioma, medulloblastoma, and other brain tumors.

This presentation was originally given as a webinar hosted by the American Brain Tumor Association:

For more information on brain tumor treatment and research, visit the website for Dana-Farber's Center for Neuro-Oncology:

Published in: Health & Medicine
  • Be the first to comment